Village Farms Delivers Another Quarter of Record Financial Performance in Q3/25

Core Insights - Village Farms International reported record financial performance in Q3 2025, with significant year-over-year increases in net income, adjusted EBITDA, and cash flow from operations [2][3] - The company achieved a 29% year-over-year growth in net sales, reaching $66.7 million, and a record gross margin of 56% [3][8] - International export sales surged by 758%, driven by strong demand in Germany and other international markets [3][14] Financial Performance - Consolidated net sales increased by 21% year-over-year to $66.7 million, up from $54.9 million [3][8] - Consolidated net income from continuing operations was $10.8 million, or $0.09 per share, compared to a net loss of $0.8 million in the prior year [3][8] - Adjusted EBITDA reached $20.2 million, representing 30.3% of sales, marking both a company record and a significant increase from $4.7 million or 8.5% of sales in the prior year [3][8] Canadian Cannabis Segment - Canadian cannabis operations delivered record net sales of $46.6 million, a 29% increase from $36.5 million [3][8] - The gross margin for Canadian cannabis improved to 56%, up from 26%, due to enhanced operating efficiency and a higher mix of international export sales [3][8] - A 40 metric ton production capacity expansion project is currently underway to support growth in Canadian and international markets [2][3] International Cannabis Segment - The Netherlands cannabis operations saw continued sales growth, with the Drachten facility reaching full operating capacity [2][3] - Construction of a second, larger facility in the Netherlands is on schedule to be operational in Q1 2026, which is expected to quintuple production capacity [2][3] Cash Flow and Capital Allocation - Operating cash flow for the quarter was $24.4 million, bringing the year-to-date total to $46.7 million, with a cash position of approximately $88 million at quarter-end [3][8] - The company initiated a share repurchase program, authorizing up to $10 million for the buyback of common shares as part of a balanced capital allocation strategy [15]